In Brief: Bioxodes To Take Novel Hemorrhagic Stroke Drug Into Registrational Trial
There are currently no approved treatments for ICH
ICH is a devastating condition, which while accounting for only 13% of all cases of stroke, is behind 40% of all stroke-related deaths. (Shutterstock) 
